Abbott's MDx Sales Fall 8 Percent in Q3 as Total Revenues Decline Slightly
October 17, 2012
Abbott's MDx Sales Fall 8 Percent in Q3 as Total Revenues Decline Slightly
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Abbott's MDx Sales Rise 4 Percent in Q4
January 23, 2013 / GenomeWeb Daily News - Abbott's MDx Sales Rise 11 Percent in Q4
January 25, 2012 / GenomeWeb Daily News - Abbott's Q4 Molecular Dx Sales Rise 21 Percent
January 26, 2011 / GenomeWeb Daily News - Abbott's MDx Sales Rise 23 Percent in Q2 2010
July 21, 2010 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider